Trial
NCT05144009
A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
ADC Therapeutics S.A.
Collaborators
—
Condition
Diffuse Large B-cell Lymphoma
Intervention
Loncastuximab Tesirine
Why stopped
The benefit-risk profile does not support continuation of the LOTIS-9 trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-30